Is the senior housing industry ready for baby boomers and solo agers? No. They will need to revamp their features, engagement level, and financial models to stay viable and attract the next generation of the oldest older adults.
Category: Forbes
Banks’ 360-Degree View Of Customers Could Include Their Mental Health
Financial difficulties and mental health are often linked, but they are usually treated separately. Silver Cloud Health has developed an online coaching program, Space from Money Worries, to help people gain confidence over money issues.
Anthem’s Focus On Medicare Over Obamacare Boosts Profits
Anthem’s decision to exit some Obamacare markets to focus on Medicare Advantage growth helped boost second quarter profits 23%.
Blood Pressure Drugs May Prevent Memory Problems, Study Says
“Even after only two and a half years of taking blood pressure lowering medication, this is a dramatic benefit to improve brain health, especially lowering risk for mild cognitive impairment,” says lead study author Jeff Williamson of Wake Forest Unive…
Centene Won’t Gobble Doctors Like Other Insurers
Centene doesn’t plan to engage in a nationwide doctor-buying binge like UnitedHealth Group’s Optum and Humana.
Essential Triathlon Training Gear
All the gadgets and gizmos you need to compete in a Tri event
Scientist Invented A New Pathway To Approve Biosimilars – And The FDA Is Listening
In an extraordinary move, the FDA has withdrawn draft guidance for biosimilars after receiving public comments and 1 citizen petition. But what makes the FDA about-face on biosimilar evaluation so monumental is that it was the direct result of the citi…
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer’s With Immunotherapy
With backing from some of biotech’s biggest players, Alector, a startup taking on Alzheimer’s disease announced Wednesday that it has raised $133 million in a Series E funding round.
23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs
GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe. The colla…
Can We Trust The Health Claims For Hyped Foods? A New Research Review Tests The Evidence
A new research review tests health claims made for several popular foods, revealing the good, bad and indifferent evidence to help make informed dietary decisions.
